BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 288 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $565,000 | -24.8% | 3,740 | -27.4% | 0.00% | -40.0% |
| Q2 2022 | $751,000 | -53.4% | 5,154 | -62.1% | 0.01% | -64.3% |
| Q1 2022 | $1,611,000 | +151.7% | 13,586 | +192.5% | 0.01% | +133.3% |
| Q4 2021 | $640,000 | -32.2% | 4,645 | -52.2% | 0.01% | -45.5% |
| Q2 2021 | $944,000 | +343.2% | 9,727 | +212.4% | 0.01% | +266.7% |
| Q1 2021 | $213,000 | -95.0% | 3,114 | -93.7% | 0.00% | -94.8% |
| Q4 2020 | $4,251,000 | +478.4% | 49,597 | +338.4% | 0.06% | +427.3% |
| Q3 2020 | $735,000 | +197.6% | 11,313 | +235.4% | 0.01% | +175.0% |
| Q2 2020 | $247,000 | -80.1% | 3,373 | -85.2% | 0.00% | -82.6% |
| Q4 2019 | $1,241,000 | +312.3% | 22,800 | +231.2% | 0.02% | +283.3% |
| Q2 2019 | $301,000 | +377.8% | 6,884 | +461.0% | 0.01% | +200.0% |
| Q1 2019 | $63,000 | -92.9% | 1,227 | -94.9% | 0.00% | -95.2% |
| Q4 2018 | $891,000 | +22.7% | 24,089 | +24.6% | 0.04% | +5.0% |
| Q3 2018 | $726,000 | +105.1% | 19,339 | +115.8% | 0.04% | +122.2% |
| Q2 2018 | $354,000 | +5.0% | 8,963 | -28.3% | 0.02% | 0.0% |
| Q4 2017 | $337,000 | +56.7% | 12,492 | +45.4% | 0.02% | +28.6% |
| Q2 2017 | $215,000 | – | 8,592 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 710,422 | $24,658,747 | 16.62% |
| Birchview Capital, LP | 7,365 | $255,639 | 0.24% |
| Itau Unibanco Holding S.A. | 88 | $3,054 | 0.00% |